L.E.K.’s Take on China Medtech: Optimistic Macro View, Short-Term Hit Hard Stephen Sunderland Read more
Related Practice MedTech Despite the COVID-19 lockdown, Stephen Sunderland foresees limited disruption 07102020100744
Article Mental and Behavioral Health A Test of Resilience: Looking Forward to Psychedelics Funding in 2023 March 7, 2023
Executive Insights Biotech and Pharmaceuticals Five Essential Factors for a Successful Biopharma Product Launch September 30, 2022
Video / Webinar MedTech APAC Hospital Priorities 2022: Strategic Implications for Medtech Firms Part 1 July 13, 2022
Video / Webinar MedTech APAC Hospital Priorities 2022: Strategic Implications for Medtech Firms Part 2 July 21, 2022
